These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7998046)

  • 21. Efficacy and tolerability of sumatriptan injection for the treatment of morning migraine: two multicenter, prospective, randomized, double-blind, controlled studies in adults.
    Winner P; Adelman J; Aurora S; Lener ME; Ames M
    Clin Ther; 2006 Oct; 28(10):1582-91. PubMed ID: 17157114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
    Tepper SJ; Cochran A; Hobbs S; Woessner M
    Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks.
    Diener HC; Bussone G; de Liano H; Eikermann A; Englert R; Floeter T; Gallai V; Göbel H; Hartung E; Jimenez MD; Lange R; Manzoni GC; Mueller-Schwefe G; Nappi G; Pinessi L; Prat J; Puca FM; Titus F; Voelker M;
    Cephalalgia; 2004 Nov; 24(11):947-54. PubMed ID: 15482357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical experience with sumatriptan ++ in the treatment of migraine symptoms].
    Pascual J
    Neurologia; 1994; 9(7):282-6. PubMed ID: 7946423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine.
    Barbanti P; Carpay JA; Kwong WJ; Ahmad F; Boswell D
    Curr Med Res Opin; 2004 Dec; 20(12):2021-9. PubMed ID: 15701219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The combination of oral lysine-acetylsalicylate and metoclopramide compared with oral sumatriptan in the treatment of migraine attacks. A randomized, double-blind, placebo-controlled clinical trial].
    Tfelt-Hansen P; Henry P; Mulder LJ; Scheldewaert RG; Schoenen J; Chazot G
    Ugeskr Laeger; 1996 Nov; 158(45):6435-9. PubMed ID: 8992678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group.
    Salonen R; Ashford EA; Gibbs M; Hassani H
    Int J Clin Pract Suppl; 1999 Aug; 105():16-24. PubMed ID: 10692718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks].
    Göbel H; Stolze H; Heinze A; Dworschak M; Heuss D; Christiani K; Lindner V
    Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
    Linde M; Mellberg A; Dahlöf C
    Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sumatriptan and general practice].
    Sjaastad O
    Tidsskr Nor Laegeforen; 1994 Nov; 114(29):3418. PubMed ID: 7998041
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.
    Tfelt-Hansen P; Bach FW; Daugaard D; Tsiropoulos I; Riddersholm B
    J Headache Pain; 2006 Dec; 7(6):389-94. PubMed ID: 17164991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind trial of clonidine in the treatment of migraine in a general practice.
    Adam EI; Gore SM; Price WH
    J R Coll Gen Pract; 1978 Oct; 28(195):587-90. PubMed ID: 368333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The migraine remedy sumatriptan (Imigran) and coronary heart disease].
    Nguyen KN; Landmark K
    Tidsskr Nor Laegeforen; 1995 May; 115(13):1636-7. PubMed ID: 7778081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid oral transmucosal absorption of sumatriptan, and pharmacodynamics in acute migraine.
    Dilone E; Bergstrom D; Cabana B; Nedumpara M; Fox AW;
    Headache; 2009; 49(10):1445-53. PubMed ID: 19549162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sumatriptan patch (Zecuity) for migraine.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):151-2. PubMed ID: 26529132
    [No Abstract]   [Full Text] [Related]  

  • 38. [Migraine and tiapride. A controlled study (author's transl)].
    Michel H
    Sem Hop; 1980 Dec 8-15; 56(45-46):1931-5. PubMed ID: 6256904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea.
    Durham PL; Vause CV; Derosier F; McDonald S; Cady R; Martin V
    Headache; 2010 May; 50(5):844-51. PubMed ID: 20353434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of sumatriptan: clinical trials and post-marketing experience.
    Welch KM; Mathew NT; Stone P; Rosamond W; Saiers J; Gutterman D
    Cephalalgia; 2000 Oct; 20(8):687-95. PubMed ID: 11167896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.